Bimekizumab demonstrated a favorable safety profile for the long-term treatment of axSpA and PsA, with rates of TEAEs remaining stable over time.

Patients with psoriatic arthritis (PsA) who were left-handed had increased peripheral damage on radiographic assessment, ...

New study shows a subset of psoriatic arthritis patients can achieve long-term remission without DMARDs. Learn who benefits ...

Biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) seem to be the most effective treatments for ...

Metabolic syndrome is associated with elevated levels of pain catastrophizing among patients with PsA and may impact disease activity.